High-Throughput Screening – News and Features

Helical nanoparticles are being used to isolate chiral drug molecules in high-throughput screening for drug discovery.

Researchers have developed the first patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism.

Contrary to previous observations in Italy, scientists, with the help of high-throughput sequencing technology, observed an explosive propagation of Grapevine Pinot gris virus in Southern France.

Technology Networks spoke to Dr. Mark Kotter, CEO and founder of bit.bio to learn about opti-ox™ and the development, benefits and applications of ioSkeletal Myocytes.

Various biopharmaceutical analysis techniques are used to gain vital insights into the composition, quality, stability and safety of complex biotherapeutics throughout the development pipeline. In this article, we take a closer look at some of the strategies employed by scientists in the field.

Chemists have created a new methodology that rapidly generates millions of combinations of small molecules through programmed assembly using DNA-pairing processes.

Cancer biologist Yibin Kang has been investigating the gene MTDH, which enables cancer in two ways. He has found a way to disable the gene in both mice and in human tissue, with a targeted experimental therapy.

Researchers have developed a 3D cell culturing platform that allows the study of lung fibroblasts and their microenvironment. The platform enables measurement of cell behaviors and changes involved in the progression of idiopathic pulmonary fibrosis.

This article will explore how high-throughput technologies are continuing to advance research in the life sciences. It will also and highlight various areas directly benefiting, including drug discovery, genomics and molecular biology.

To learn more about Life Chemicals and the services it provides, Technology Networks spoke with Olga Balabon. In this interview, Olga also highlights how the company supports researchers when searching for appropriate product candidates.